Search Results for: CGRP
Trending Drug PricingDrug ManufacturingMedication
New Trends of Hospital Pharmacy Expenditure: Specialty and Neurology Medications are Escalating
2023-08-09
Trials & Approvals Migraine
Pfizer’s Fast-Acting Migraine Nasal Spray Takes Home US Approval
2023-03-13
Trials & Approvals Migraine
Pfizer Trumpets Lancet Publication Of Migraine Drug’s Phase 3 Results
2023-02-18
Special biopharmam&a
GeneOnline’s Pick: Top 10 M&A Deals in 2022
2022-12-28
M&A Pfizer
Pfizer Buys Biohaven For $11.6 Billion, Bags Migraine Asset
2022-05-11
Ranking & Reports FDA Approved
GeneOnline’s Pick: Notable Novel FDA Approved Drugs in 2021
2022-01-05
Trials & Approvals Migraine
Amgen Announces Encouraging Full Data for Migraine Drug, Aimovig
2021-11-09
Asia-Pacific Japan
Daiichi Sankyo Partners with Lilly on a Second Migraine Drug Deal in Japan
2021-09-01
R&D Anti-CGRP
Spotlight: The Revitalization of Chronic Migraine Therapies
2020-09-02
Weekly Asia Highlights- China and Japan
2020-08-06
Trials & Approvals
Ubrelvy Approval, the Best New Year Gift for CGRP Migraine Victims
2020-01-09
Ranking & Reports Lung Cancer
Weekly Top 5 in China (0210-0216)
2019-02-18
Manufacturing Migraine
Clash of three migraines medications & cost benefit for patients
2018-10-01
Trials & Approvals Migraine
AJOVY™, Teva’s new migraine drug gets USFDA approval
2018-09-21
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top